Ceftolozane/Tazobactam-Induced Leukocytosis and Clinical Failure in a Patient Being Treated for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant Pseudomonas aeruginosa: a Case Report

Ceftolozane/tazobactam is an intravenous beta-lactam/beta-lactamase inhibitor that utilizes a novel oxyimino-cephalosporin with a traditional beta-lactamase inhibitor. It is approved by the Food and Drug Administration to treat complicated intra-abdominal infections in combination with metronidazole...

Descripción completa

Detalles Bibliográficos
Autores principales: Maniara, Bejoy P., Wells, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818065/
https://www.ncbi.nlm.nih.gov/pubmed/33495748
http://dx.doi.org/10.1007/s42399-021-00750-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7818065/
https://www.ncbi.nlm.nih.gov/pubmed/33495748
http://dx.doi.org/10.1007/s42399-021-00750-5

Ejemplares similares